Corrigendum to "Parallel explorations in LA-NSCLC: Chemoradiation dose-response optimisation considering immunotherapy and cardiac toxicity sparing" [Radiother. Oncol. 200 (2024) 110477]

Radiother Oncol. 2024 Dec 14:203:110666. doi: 10.1016/j.radonc.2024.110666. Online ahead of print.
No abstract available

Publication types

  • Published Erratum